A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

Brain

Volumn 125, Issue 7, 2002, Pages 1450-1461

  Lucchinetti, Claudia F ^a   Mandler, Raul N ^c   McGavern, Dorian ^b   Bruck, Wolfgang ^g   Gleich, Gerald ^b   Ransohoff, Richard M ^d   Trebst, Corinna ^d   Weinshenker, Brian ^a   Wingerchuk, Dean ^e   Parisi, Joseph E ^a   Lassmann, Hans ^f  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f Brain Research Institute   (Austria)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Devic's syndrome; Eosinophils; Humoral immunity; Neuromyelitis optica; Neuropathology

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN M;

ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOCYTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MORPHOMETRICS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036310181     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf151     Document Type: Article

References (55)

1. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: Clinicopathologic report and review of the literature
2. Complement as a promiscuous signal transduction device
3. Plasmapheresis in multiple sclerosis patients with different indications
4. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus
5. In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain
6. Monocyte/macrophage differentiation in early multiple sclerosis lesions
7. Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice
8. Eosinophilic vasculitis in connective tissue disease
9. Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trial
10. Neuromyelitis optica
11. T-cell/eosinophil interactions in the induction of asthma
12. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
13. Myelitis subaigue corapliquess de neurite optique
14. Myelite aigue dorse-lornbaire de neurite optique, autopsie
15. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma
16. Mixed connective tissue disease: Recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis
17. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
18. Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis
19. Acute and chronic experimental optic neuritis. Alteration in the blood-optic nerve barrier
20. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica
21. Haemorrhagic and perivenous encephalitis: A clinical-pathological review of 38 cases
22. Regulation of antibody responses via antibodies, complement, and Fc receptors
23. Eosinophil basic proteins
24. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils
25. Devic's syndrome and systemic lupus erythematosus: A case report with necropsy
26. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjogren's syndrome
27. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis
28. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies
29. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
30. Devic's neuromyelitis optica: A clinicopathological study of 8 patients
31. Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine
32. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica
33. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica
34. Steroid-responsive Devic's variant in Sjogren's syndrome
35. Physiology and pathophysiology of complement progress and trends
36. Hypergammaglobulinemic purpura associated with multiple sclerosis
37. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica
38. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
39. Demyelinating diseases
40. Chronic experimental allergic optic neuritis
41. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice
42. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma
43. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
44. Racial modification of clinical picture of multiple sclerosis: Comparison between British and Japanese patients
45. Transverse myelitis in systemic lupus erythematosus: Two cases with magnetic resonance imaging
46. Cerebrospinal fluid eosinophilia: A manifestation of a disorder resembling multiple sclerosis in childhood
47. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
48. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
49. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
50. Multiple sclerosis associated with eosinophilic vasculitis, pericarditis, and hypocomplementemia
51. Intrathecal application of interferon gamma: Progressive appearance of MHC antigens within the rat nervous system
52. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP): A new clinical approach to asthma management
53. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
54. The clinical course of neuromyelitis optica (Devic's syndrome)